Several Noncontiguous Domains of CDK4 Are Involved in Binding to the P16 Tumor Suppressor Protein

This publication has 17 references indexed in Scilit:

• CDKN2AMutations in Multiple Primary Melanomas
  New England Journal of Medicine, 1998
• Foundations in Cancer Research p53 and ATM: Cell Cycle, Cell Death, and Cancer
  Published by Elsevier ,1997
• Cancer Cell Cycles
  Science, 1996
• Cancer-associated mis-sense and deletion mutations impair p16INK4 CDK inhibitory activity
  International Journal of Cancer, 1996
• Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas
  British Journal of Cancer, 1996
• Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma
  Nature Genetics, 1996
• A p16 ^INK4a -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human Melanoma
  Science, 1995
• Mammalian G1 cyclins
  Current Opinion in Cell Biology, 1994
• Response : Rates of p16 ( MTS1 ) Mutations in Primary Tumors with 9p Loss
  Science, 1994
• Mutations at sites involved in Suc1 binding inactivate Cdc2.
  Molecular and Cellular Biology, 1991